Standard BioTools SG&A Expenses 2010-2025 | LAB
Standard BioTools sg&a expenses from 2010 to 2025. Sg&a expenses can be defined as the sum of all selling, general and administrative expenses.
| Standard BioTools Annual SG&A Expenses (Millions of US $) |
|
|---|---|
| 2024 | $157 |
| 2023 | $88 |
| 2022 | $102 |
| 2021 | $99 |
| 2020 | $98 |
| 2019 | $84 |
| 2018 | $80 |
| 2017 | $80 |
| 2016 | $93 |
| 2015 | $83 |
| 2014 | $71 |
| 2013 | $48 |
| 2012 | $38 |
| 2011 | $31 |
| 2010 | $24 |
| 2009 | $20 |
| Standard BioTools Quarterly SG&A Expenses (Millions of US $) |
|
|---|---|
| 2025-03-31 | $39 |
| 2024-12-31 | $38 |
| 2024-09-30 | $34 |
| 2024-06-30 | $38 |
| 2024-03-31 | $47 |
| 2023-12-31 | $21 |
| 2023-09-30 | $22 |
| 2023-06-30 | $23 |
| 2023-03-31 | $21 |
| 2022-12-31 | $15 |
| 2022-09-30 | $26 |
| 2022-06-30 | $30 |
| 2022-03-31 | $31 |
| 2021-12-31 | $23 |
| 2021-09-30 | $24 |
| 2021-06-30 | $24 |
| 2021-03-31 | $28 |
| 2020-12-31 | $32 |
| 2020-09-30 | $23 |
| 2020-06-30 | $21 |
| 2020-03-31 | $23 |
| 2019-12-31 | $19 |
| 2019-09-30 | $21 |
| 2019-06-30 | $22 |
| 2019-03-31 | $23 |
| 2018-12-31 | $22 |
| 2018-09-30 | $20 |
| 2018-06-30 | $19 |
| 2018-03-31 | $19 |
| 2017-12-31 | $16 |
| 2017-09-30 | $20 |
| 2017-06-30 | $21 |
| 2017-03-31 | $23 |
| 2016-12-31 | $23 |
| 2016-09-30 | $21 |
| 2016-06-30 | $24 |
| 2016-03-31 | $25 |
| 2015-12-31 | $22 |
| 2015-09-30 | $20 |
| 2015-06-30 | $21 |
| 2015-03-31 | $20 |
| 2014-12-31 | $19 |
| 2014-09-30 | $19 |
| 2014-06-30 | $19 |
| 2014-03-31 | $15 |
| 2013-12-31 | $14 |
| 2013-09-30 | $12 |
| 2013-06-30 | $12 |
| 2013-03-31 | $11 |
| 2012-12-31 | $11 |
| 2012-09-30 | $9 |
| 2012-06-30 | $9 |
| 2012-03-31 | $9 |
| 2011-12-31 | $8 |
| 2011-09-30 | $8 |
| 2011-06-30 | $8 |
| 2011-03-31 | $7 |
| 2010-12-31 | $6 |
| 2010-09-30 | $6 |
| 2010-06-30 | $6 |
| 2010-03-31 | $6 |
| 2009-09-30 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.467B | $0.174B |
| Standard BioTools Inc. is a solution provider in health and disease using its proprietary mass cytometry and microfluidics technologies. It serves academic, government, pharmaceutical, biotechnology, plant and animal research and clinical laboratories. Standard BioTools Inc., formerly known as Fluidigm Corporation, is based in SOUTH SAN FRANCISCO, Calif. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $45.804B | 58.27 |
| Tempus AI (TEM) | United States | $11.365B | 0.00 |
| Doximity (DOCS) | United States | $10.890B | 50.42 |
| Hims & Hers Health (HIMS) | United States | $9.396B | 97.63 |
| IRhythm Technologies (IRTC) | United States | $4.819B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $3.834B | 59.90 |
| Hinge Health (HNGE) | United States | $3.409B | 0.00 |
| Privia Health (PRVA) | United States | $2.635B | 180.08 |
| Enovis (ENOV) | United States | $1.711B | 9.54 |
| Phreesia (PHR) | United States | $1.608B | 0.00 |
| Schrodinger (SDGR) | United States | $1.493B | 0.00 |
| Clover Health Investments (CLOV) | United States | $1.440B | 0.00 |
| Azenta (AZTA) | United States | $1.334B | 61.98 |
| Omnicell (OMCL) | United States | $1.329B | 23.45 |
| 10x Genomics (TXG) | United States | $1.329B | 0.00 |
| Evolent Health (EVH) | United States | $1.233B | 105.00 |
| Claritev (CTEV) | United States | $0.682B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.588B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.507B | 0.00 |
| Veradigm (MDRX) | United States | $0.486B | 0.00 |
| Talkspace (TALK) | United States | $0.462B | 138.00 |
| TruBridge (TBRG) | United States | $0.337B | 748.33 |
| Outset Medical (OM) | United States | $0.308B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.267B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.261B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.203B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.158B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.133B | 0.00 |
| CareCloud (CCLD) | United States | $0.105B | 4.02 |
| American Well (AMWL) | United States | $0.105B | 0.00 |
| Pulmonx (LUNG) | United States | $0.103B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.099B | 0.00 |
| 111 (YI) | China | $0.066B | 0.00 |
| HeartBeam (BEAT) | United States | $0.050B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.044B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.044B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.035B | 0.00 |
| Zhongchao (ZCMD) | China | $0.032B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.022B | 0.00 |
| Precipio (PRPO) | United States | $0.016B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.014B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.013B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.010B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.010B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.008B | 0.00 |
| Movano (MOVE) | United States | $0.005B | 0.00 |
| HeartSciences (HSCS) | United States | $0.004B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.004B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.003B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |